Literature DB >> 24357404

Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial.

John P Greenwood1, Manish Motwani, Neil Maredia, Julia M Brown, Colin C Everett, Jane Nixon, Petra Bijsterveld, Catherine J Dickinson, Stephen G Ball, Sven Plein.   

Abstract

BACKGROUND: Coronary artery disease is the leading cause of death in women, and underdiagnosis contributes to the high mortality. This study compared the sex-specific diagnostic performance of cardiovascular magnetic resonance (CMR) and single-photon emission computed tomography (SPECT). METHODS AND
RESULTS: A total of 235 women and 393 men with suspected angina underwent CMR, SPECT, and x-ray angiography as part of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) study. CMR comprised adenosine stress/rest perfusion, cine imaging, late gadolinium enhancement, and magnetic resonance coronary angiography. Gated adenosine stress/rest SPECT was performed with (99m)Tc-tetrofosmin. For CMR, the sensitivity in women and men was similar (88.7% versus 85.6%; P=0.57), as was the specificity (83.5% versus 82.8%; P=0.86). For SPECT, the sensitivity was significantly worse in women than in men (50.9% versus 70.8%; P=0.007), but the specificities were similar (84.1% versus 81.3%; P=0.48). The sensitivity in both the female and male groups was significantly higher with CMR than SPECT (P<0.0001 for both), but the specificity was similar (P=0.77 and P=1.00, respectively). For perfusion-only components, CMR outperformed SPECT in women (area under the curve, 0.90 versus 0.67; P<0.0001) and in men (area under the curve, 0.89 versus 0.74; P<0.0001). Diagnostic accuracy was similar in both sexes with perfusion CMR (P=1.00) but was significantly worse in women with SPECT (P<0.0001).
CONCLUSIONS: In both sexes, CMR has greater sensitivity than SPECT. Unlike SPECT, there are no significant sex differences in the diagnostic performance of CMR. These findings, plus an absence of ionizing radiation exposure, mean that CMR should be more widely adopted in women with suspected coronary artery disease. CLINICAL TRIAL REGISTRATION URL: http://www.controlled-trials.com. Unique identifier: ISRCTN77246133.

Entities:  

Keywords:  magnetic resonance imaging; myocardial ischemia; tomography, emission-computed, single-photon; women

Mesh:

Substances:

Year:  2013        PMID: 24357404     DOI: 10.1161/CIRCULATIONAHA.112.000071

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  51 in total

Review 1.  Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes.

Authors:  David P Ripley; Manish Motwani; Sven Plein; John P Greenwood
Journal:  Quant Imaging Med Surg       Date:  2014-10

Review 2.  Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.

Authors:  Lauren A Baldassarre; Subha V Raman; James K Min; Jennifer H Mieres; Martha Gulati; Nanette K Wenger; Thomas H Marwick; Chiara Bucciarelli-Ducci; C Noel Bairey Merz; Dipti Itchhaporia; Keith C Ferdinand; Carl J Pepine; Mary Norine Walsh; Jagat Narula; Leslee J Shaw
Journal:  JACC Cardiovasc Imaging       Date:  2016-04

3.  Coronary Artery Disease: Analysis of Diagnostic Performance of CT Perfusion and MR Perfusion Imaging in Comparison with Quantitative Coronary Angiography and SPECT-Multicenter Prospective Trial.

Authors:  Matthias Rief; Marcus Y Chen; Andrea L Vavere; Benjamin Kendziora; Julie M Miller; W Patricia Bandettini; Christopher Cox; Richard T George; João Lima; Marcelo Di Carli; Michail Plotkin; Elke Zimmermann; Michael Laule; Peter Schlattmann; Andrew E Arai; Marc Dewey
Journal:  Radiology       Date:  2017-09-25       Impact factor: 11.105

Review 4.  Stress echocardiography: what is new and how does it compare with myocardial perfusion imaging and other modalities?

Authors:  Marysia S Tweet; Adelaide M Arruda-Olson; Nandan S Anavekar; Patricia A Pellikka
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

Review 5.  Cardiac imaging: working towards fully-automated machine analysis & interpretation.

Authors:  Piotr J Slomka; Damini Dey; Arkadiusz Sitek; Manish Motwani; Daniel S Berman; Guido Germano
Journal:  Expert Rev Med Devices       Date:  2017-03       Impact factor: 3.166

Review 6.  Cardiac CT for myocardial ischaemia detection and characterization--comparative analysis.

Authors:  A M Bucher; C N De Cecco; U J Schoepf; R Wang; F G Meinel; S R Binukrishnan; J V Spearman; T J Vogl; B Ruzsics
Journal:  Br J Radiol       Date:  2014-08-19       Impact factor: 3.039

Review 7.  Coronary microvascular dysfunction: mechanisms and functional assessment.

Authors:  Paolo G Camici; Giulia d'Amati; Ornella Rimoldi
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

8.  PET should not replace routine SPECT MPS for the assessment of patients with known or suspected CAD.

Authors:  James E Stirrup; S Richard Underwood
Journal:  J Nucl Cardiol       Date:  2017-08-23       Impact factor: 5.952

Review 9.  The role of stress cardiac magnetic resonance in women.

Authors:  Andrea Cardona; Karolina M Zareba; Subha V Raman
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

10.  Stress Cardiac MRI in Women With Myocardial Infarction and Nonobstructive Coronary Artery Disease.

Authors:  Rina Mauricio; Monvadi B Srichai; Leon Axel; Judith S Hochman; Harmony R Reynolds
Journal:  Clin Cardiol       Date:  2016-07-26       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.